// App-Quantinova.ai

BSH2020‐OR‐028 : Sequential MATRIX‐RICE therapy followed by autologous stem cell transplant in patients with diffuse large B‐cell lymphoma and secondary central nervous system involvement: the International Extranodal Lymphoma Study Group‐42 Phase II (MARIETTA) Trial

Researchers

Presenter

  • K. Cwynarski

Principal Investigators

  • J. Smith

  • K. Linton

  • P. McKay

  • K. Cozens

  • A. Davies

  • C. Fox

  • W. Osborne

  • J. Khwaja

  • V. Singh

  • C. Cattaneo

  • M. Giuseppina Cabras

  • F. Ilariucci

  • F. Narni

  • T. Calimeri

  • A. Re

  • B. Botto

  • C. Cellini

  • L. Nassi

  • J. Olivieri

  • C. Patti

  • F. Re

  • A. Fanni

  • J. Bromberg

  • E. Gastaldi

  • N. Cascavilla

  • M. Frezzato

  • A. M. Liberati

  • U. Novak

  • R. Zambello

  • E. Zucca

  • A. Ferreri

Medical Centers

  • Rheumatology, UCL, London, UK

  • Department of Hematology, Erasmus MC Cancer Insitute, Rotterdam, Netherlands

  • Haematology, Aintree Hospital, Liverpool

  • Haematology, The Christie, Manchester

  • Haematology, Beatson Cancer Centre, Glasgow

  • Clinical Trials Unit

  • Cancer Research UK Centre, University of Southampton,Southampton,Royaume-uni

  • Nottingham University Hospitals NHS Trust, Nottingham,

  • Haematology, NUTH, Newcastle, UK

  • Hematology, Spedali Civili, Brescia

  • Haematology, Ospedale Oncologico Buscino, Cagliari

  • Haematology, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia

  • Haematology, Policlinico Universitario, Modena

  • Hematology, San Raffaele Scientific Institute,

  • Rheumatology, Città della salute e della scienza, Torino

  • Haematology, Ospedale di Ravenna IRST, Ravenna

  • Department of Translational Medicine, University of Eastern Piedmont, Ospedale Maggiore della Carità Novara, Novara, Italy

  • Haematology, AOU ‘Santa Maria della Misericordia’, Udine

  • Haematology, Villa Sofia, Palermo

  • Haematology, AO Parma, Parma

  • Hematology Unit, Ospedale Oncologico A. Businco,Cagliari,Italy

  • International Extranodal Lymphoma Study Group, 1IELSG, Bellinzona, Switzerland

  • Haematology, Casa Sollievo della Sofferenza, San Giovanni Rotondo

  • Hematology Department, San Bortolo Hospital,Vicenza, Italy

  • Haematology, Ospedale di Terni, Terni, Italy

  • Haematology, Hospital of Bern, Bern, Switzerland

  • Haematology, Azienda Ospedaliera di Padova, Padua

  • IOSI, and IELSG, Bellinzona

  • Radiotherapy, IRCCS San Raffaele Scientific Institute, Milano, Italy

Locations

  • United Kingdom

  • Netherlands

  • Italy

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • Methotrexate

  • Thiotepa

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • II

Study Id's

  • NCT02329080

Sponsors

  • N/A

Result

  • N/A